Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
GlobeNewswire

Company announcement No. 36 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) Copenhagen, Denmark, August 3, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

axios.com - Tina Reed - How a pharma megamerger could squelch R&D
How a pharma megamerger could squelch R&D
Axios

Big drug companies have been buying scrappy biotechs to expand their pipelines, but the potential megamerger between AstraZeneca and Bristol Myers Squibb could flip that script. Why it matters: Combining two drug giants with overlapping portfolios…

smh.com.au - Murray Ward - Amplia teams up with big pharma for lung cancer trial
Amplia teams up with big pharma for lung cancer trial
The Sydney Morning Herald

Melbourne-based ASX listed biotech Amplia Therapeutics has secured a major collaboration with pharmaceutical goliath Eli Lilly & Company to evaluate a new combination therapy aimed at tackling non-small cell lung cancer (NSCLC). The two companies…

bloomberg.com - Ashleigh Furlong - Why a Potential Astra-Bristol Merger Looks Like Pharma's FIFA Moment
Why a Potential Astra-Bristol Merger Looks Like Pharma's FIFA Moment
Bloomberg

This article is for subscribers only. Hi, it's Ashleigh Furlong in London and Sonja Wind in Frankfurt, looking at the immediate reaction to news of a potential megamerger in the global pharmaceuticals industry. Also today, Italy's Prysmian extends…

newswire.ca - Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
CNW

Piramal Pharma Solutions has added a new spray drying suite with Band 5 containment capacity at its dedicated peptide facility in Turbhe, India, equipped with its own air handling units, nitrogen supply, and control systems. The new suite empowers…

axios.com - Dan Primack - Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
Axios

AstraZeneca has had merger talks with Bristol-Myers Squibb, according to the Financial Times. Why it matters: A tie-up would create the world's fourth most valuable drugmaker, with around $400 billion in combined market cap. Investor reax:…

thehindubusinessline.com - Alembic Pharma Q1 net profit up 12.1% at ₹173.07 cr
Alembic Pharma Q1 net profit up 12.1% at ₹173.07 cr
BusinessLine

Alembic Pharmaceuticals Ltd on Tuesday reported a 12.1 per cent rise in consolidated net profit to ₹173.07 crore in the first quarter ended June on the back of broad-based growth across businesses. The company had posted a consolidated net…

thehindubusinessline.com - India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says
India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says
BusinessLine

India's pharmaceutical industry is likely to miss its sales target for the end ​of the decade as U.S. tariff uncertainty and Middle East shipping ‌disruptions weigh on exports, the head of a government-backed ​trade body told…

marketbeat.com - Pacer Advisors Inc. Lowers Holdings in Royalty Pharma PLC $RPRX
Pacer Advisors Inc. Lowers Holdings in Royalty Pharma PLC $RPRX
MarketBeat

Pacer Advisors Inc. reduced its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 24.6% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 689,194 shares of…

marketbeat.com - Eastern Bank Has $38.96 Million Position in Royalty Pharma PLC $RPRX
Eastern Bank Has $38.96 Million Position in Royalty Pharma PLC $RPRX
MarketBeat

Eastern Bank lifted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 694,925…

marketbeat.com - BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Rating of 'Moderate Buy' from Analysts
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Rating of 'Moderate Buy' from Analysts
MarketBeat

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have received a consensus rating of 'Moderate Buy' from the twenty-three analysts that are currently covering the company, MarketBeat reports. One equities research analyst has rated…

marketbeat.com - Dimensional Fund Advisors LP Purchases 179,376 Shares of BridgeBio Pharma, Inc. $BBIO
Dimensional Fund Advisors LP Purchases 179,376 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Dimensional Fund Advisors LP increased its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 46.9% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 561,945 shares of…

marketbeat.com - California State Teachers Retirement System Boosts Stock Position in BridgeBio Pharma, Inc. $BBIO
California State Teachers Retirement System Boosts Stock Position in BridgeBio Pharma, Inc. $BBIO
MarketBeat

California State Teachers Retirement System boosted its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 23.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0647 GMT – Bayer reported strong results for the second quarter and reiterated its full-year guidance…

thehindu.com - V. Swathi - Musi river sediment free of hazardous material, says MRDCL; activists dispute claim
Musi river sediment free of hazardous material, says MRDCL; activists dispute claim
The Hindu

The sediment in the Musi River stretch between the twin reservoirs and Bapughat, earmarked for development under Phase I of the Musi Riverfront Development Project, is free of hazardous material, the authorities of Musi Riverfront Development…

Receive a Daily briefing on Pharma Industry News

Get Started